Which of the following is considered a relative contraindication for Uterine Artery Embolization (UAE)?

Uterine Artery Embolization (UAE) is primarily used to treat symptomatic uterine fibroids, and is generally well-regarded for patients presenting with these conditions. However, its use can be influenced by various factors, including the presence of contraindications.

In this scenario, considering asymptomatic fibroids as a relative contraindication makes sense because UAE is typically reserved for individuals with symptomatic fibroids that are causing significant problems, such as heavy menstrual bleeding or pain. Performing UAE on asymptomatic fibroids could expose the patient to unnecessary risks associated with the procedure without providing any tangible benefit, as these fibroids may not be causing issue and could potentially be managed through observation alone.

In contrast, uterine malignancy represents an absolute contraindication since embolizing a uterine artery in this context could lead to worsened outcomes or complicate the management of cancer. Similarly, pelvic inflammatory disease and advanced age do not inherently contraindicate the procedure, although certain considerations may need to be made depending on the patient's overall health and the specifics of their condition.

Thus, identifying asymptomatic fibroids as a relative contraindication highlights the importance of patient selection for UAE, ensuring that interventions are not performed unnecessarily.